mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.7 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
-0.072 |
0.7 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.7 |